Screening for functional transcriptional and splicing regulatory variants with GenIE.


Journal

Nucleic acids research
ISSN: 1362-4962
Titre abrégé: Nucleic Acids Res
Pays: England
ID NLM: 0411011

Informations de publication

Date de publication:
16 12 2020
Historique:
accepted: 08 10 2020
revised: 22 09 2020
received: 28 07 2020
pubmed: 6 11 2020
medline: 14 1 2021
entrez: 5 11 2020
Statut: ppublish

Résumé

Genome-wide association studies (GWAS) have identified numerous genetic loci underlying human diseases, but a fundamental challenge remains to accurately identify the underlying causal genes and variants. Here, we describe an arrayed CRISPR screening method, Genome engineering-based Interrogation of Enhancers (GenIE), which assesses the effects of defined alleles on transcription or splicing when introduced in their endogenous genomic locations. We use this sensitive assay to validate the activity of transcriptional enhancers and splice regulatory elements in human induced pluripotent stem cells (hiPSCs), and develop a software package (rgenie) to analyse the data. We screen the 99% credible set of Alzheimer's disease (AD) GWAS variants identified at the clusterin (CLU) locus to identify a subset of likely causal variants, and employ GenIE to understand the impact of specific mutations on splicing efficiency. We thus establish GenIE as an efficient tool to rapidly screen for the role of transcribed variants on gene expression.

Identifiants

pubmed: 33152068
pii: 5957169
doi: 10.1093/nar/gkaa960
pmc: PMC7736817
doi:

Substances chimiques

CLU protein, human 0
Clusterin 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e131

Subventions

Organisme : Wellcome Trust
ID : 206194
Pays : United Kingdom

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of Nucleic Acids Research.

Références

Nature. 2016 Jan 28;529(7587):490-5
pubmed: 26735016
Science. 2016 Apr 29;352(6285):600-4
pubmed: 27126046
Nat Biotechnol. 2017 Jun;35(6):561-568
pubmed: 28369033
Proc Natl Acad Sci U S A. 2017 Aug 15;114(33):E6962-E6971
pubmed: 28701379
Nature. 2016 Apr 20;533(7603):420-4
pubmed: 27096365
Nucleic Acids Res. 2019 Nov 4;47(19):e116
pubmed: 31392986
Methods Mol Biol. 2011;733:279-98
pubmed: 21431778
Elife. 2016 Mar 17;5:
pubmed: 26987018
Front Neurosci. 2018 Jul 25;12:504
pubmed: 30090055
Genome Res. 2017 Jul;27(7):1099-1111
pubmed: 28356322
Bioinformatics. 2010 Mar 1;26(5):589-95
pubmed: 20080505
Exp Neurol. 1995 Nov;136(1):22-31
pubmed: 7589331
Cell. 2019 Jan 24;176(3):535-548.e24
pubmed: 30661751
Nature. 2011 Oct 12;478(7369):391-4
pubmed: 21993621
Bioinformatics. 2011 Nov 1;27(21):2957-63
pubmed: 21903629
Nat Genet. 2017 Apr;49(4):600-605
pubmed: 28218759
Nat Commun. 2017 Dec 13;8(1):2109
pubmed: 29235467
Genet Epidemiol. 2009 Jan;33(1):79-86
pubmed: 18642345
Nature. 2019 Dec;576(7785):149-157
pubmed: 31634902
Cell Stem Cell. 2017 Apr 6;20(4):547-557.e7
pubmed: 28388431
Biol Methods Protoc. 2020 Mar 28;5(1):bpaa008
pubmed: 32665975
Science. 2017 Jun 23;356(6344):
pubmed: 28546318
Genome Res. 2017 Jan;27(1):38-52
pubmed: 27831498
Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10843-8
pubmed: 12145324
Nature. 2017 Nov 23;551(7681):464-471
pubmed: 29160308
Nat Genet. 2012 Dec;44(12):1294-301
pubmed: 23104008
Nucleic Acids Res. 2019 Jan 8;47(D1):D1005-D1012
pubmed: 30445434
Neuron. 2004 Jan 22;41(2):193-202
pubmed: 14741101
Methods Mol Biol. 2019;1961:153-183
pubmed: 30912046
Stem Cell Reports. 2018 Oct 9;11(4):897-911
pubmed: 30245212
Nat Genet. 2016 Feb;48(2):206-13
pubmed: 26656845
Cell. 2019 Jan 10;176(1-2):377-390.e19
pubmed: 30612741
BMC Bioinformatics. 2016 Nov 25;17(1):483
pubmed: 27884101
Nat Protoc. 2012 Oct;7(10):1836-46
pubmed: 22976355

Auteurs

Sarah E Cooper (SE)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK.
OpenTargets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK.

Jeremy Schwartzentruber (J)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK.
OpenTargets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK.
European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.

Erica Bello (E)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK.
OpenTargets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK.

Eve L Coomber (EL)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK.

Andrew R Bassett (AR)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK.
OpenTargets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH